Skin Immunity to Candida albicans

Trends in Immunology

Volumn 37, Issue 7, 2016, Pages 440-450

  Kashem, Sakeen W ^a   Kaplan, Daniel H ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23; LECTIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; CANDIDA ALBICANS; CELL COMPARTMENTALIZATION; EFFECTOR CELL; FUNGUS IMMUNITY; GAMMA DELTA T LYMPHOCYTE; HUMAN; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; NEUTROPHIL; NONHUMAN; REVIEW; SKIN CANDIDIASIS; SKIN NERVE; STROMA CELL; TH1 CELL; TH17 CELL; ANIMAL; ANTIBODY SPECIFICITY; CANDIDIASIS; GENETIC PREDISPOSITION; IMMUNITY; IMMUNOLOGY; MICROBIOLOGY; MOUSE; OPPORTUNISTIC INFECTION; SKIN;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY; MICE; OPPORTUNISTIC INFECTIONS; ORGAN SPECIFICITY; SKIN;

EID: 84975154530     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2016.04.007     Document Type: Review

References (109)

1. 1 Perlroth, J., et al. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med. Mycol. 45 (2007), 321–346.
2. 2 Underhill, D.M., Pearlman, E., Immune interactions with pathogenic and commensal fungi: a two-way street. Immunity 43 (2015), 845–858.
3. 3 Milner, J.D., Holland, S.M., The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases. Nat. Rev. Immunol. 13 (2013), 635–648.
4. 4 Smeekens, S.P., et al. Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nat. Commun., 4, 2013, 1342.
5. 5 Kashem, S.W., et al. Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation. Immunity 42 (2015), 356–366.
6. 6 Bar, E., et al. IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells. Immunity 40 (2014), 117–127.
7. 7 LeibundGut-Landmann, S., et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8 (2007), 630–638.
8. 8 Kumamoto, C.A., Inflammation and gastrointestinal Candida colonization. Curr. Opin. Microbiol. 14 (2011), 386–391.
9. 9 Cassone, A., Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects. BJOG 122 (2015), 785–794.
10. 10 Conti, H.R., Gaffen, S.L., IL-17-mediated immunity to the opportunistic fungal pathogen Candida albicans. J. Immunol. 195 (2015), 780–788.
11. 11 Iliev, I.D., et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336 (2012), 1314–1317.
12. 12 Igyártó, B.Z., et al. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 35 (2011), 260–272.
13. 13 Kagami, S., et al. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J. Immunol. 185 (2010), 5453–5462.
14. + dermal dendritic cells and drive protective cutaneous immunity. Immunity 43 (2015), 515–526.
15. 15 Dambuza, I.M., Brown, G.D., C-type lectins in immunity: recent developments. Curr. Opin. Immunol. 32 (2015), 21–27.
16. 16 Brown, G.D., Gordon, S., A new receptor for beta-glucans. Nature 413 (2001), 36–37.
17. 17 Glocker, E.-O., et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 361 (2009), 1727–1735.
18. 18 Ferwerda, B., et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361 (2009), 1760–1767.
19. 19 Taylor, P.R., et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8 (2007), 31–38.
20. 20 Saijo, S., et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8 (2007), 39–46.
21. 21 Marakalala, M.J., et al. Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1. PLoS Pathog., 9, 2013, e1003315.
22. 22 Gantner, B.N., et al. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 24 (2005), 1277–1286.
23. 23 Gow, N.A.R., et al. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat. Rev. Microbiol. 10 (2012), 112–122.
24. 24 Takeda, K., et al. Toll-like receptors. Annu. Rev. Immunol. 21 (2003), 335–376.
25. 25 Gantner, B.N., et al. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197 (2003), 1107–1117.
26. 26 Ferwerda, G., et al. Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell. Microbiol. 10 (2008), 2058–2066.
27. 27 Bellocchio, S., et al. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol. 172 (2004), 3059–3069.
28. 28 Haley, K., et al. Langerhans cells require MyD88-dependent signals for Candida albicans response but not for contact hypersensitivity or migration. J. Immunol. 188 (2012), 4334–4339.
29. 29 Picard, C., et al. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency. Clin. Microbiol. Rev. 24 (2011), 490–497.
30. 30 Lanternier, F., et al. Primary immunodeficiencies underlying fungal infections. Curr. Opin. Pediatr. 25 (2013), 736–747.
31. 31 Martinon, F., et al. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27 (2009), 229–265.
32. 32 Rehaume, L.M., et al. Lessons from the inflammasome: a molecular sentry linking Candida and Crohn's disease. Trends Immunol. 31 (2010), 171–175.
33. 33 Lev-Sagie, A., et al. Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndrome. Am. J. Obstet. Gynecol., 200, 2009 303.e1–6.
34. 34 Hise, A.G., et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5 (2009), 487–497.
35. 35 Joly, S., et al. Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J. Immunol. 183 (2009), 3578–3581.
36. 36 Joly, S., et al. Cutting edge: Nlrp10 is essential for protective antifungal adaptive immunity against Candida albicans. J. Immunol. 189 (2012), 4713–4717.
37. 37 Eisenbarth, S.C., et al. NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells. Nature 484 (2012), 510–513.
38. 38 Krishnaswamy, J.K., et al. Coincidental loss of DOCK8 function in NLRP10-deficient and C3H/HeJ mice results in defective dendritic cell migration. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 3056–3061.
39. 39 Farmand, S., Sundin, M., Hyper-IgE syndromes: recent advances in pathogenesis, diagnostics and clinical care. Curr. Opin. Hematol. 22 (2015), 12–22.
40. 40 Tomalka, J., et al. A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog., 7, 2011, e1002379.
41. 41 Ali, R.S., et al. Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J. Invest. Dermatol. 117 (2001), 106–111.
42. 42 Jennemann, R., et al. Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum. Mol. Genet. 21 (2012), 586–608.
43. 43 Lopez, C.M., et al. Candida albicans uses the surface protein Gpm1 to attach to human endothelial cells and to keratinocytes via the adhesive protein vitronectin. PLoS ONE, 9, 2014, e90796.
44. 44 Liang, S.C., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203 (2006), 2271–2279.
45. 45 Nograles, K.E., et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159 (2008), 1092–1102.
46. 46 Nagao, K., et al. Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. Nat. Immunol. 13 (2012), 744–752.
47. 47 Mohammed, J., et al. Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-β. Nat. Immunol. 17 (2016), 414–421.
48. 48 Bobr, A., et al. Autocrine/paracrine TGF-β1 inhibits Langerhans cell migration. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 10492–10497.
49. 49 Gasque, P., Jaffar-Bandjee, M.C., The immunology and inflammatory responses of human melanocytes in infectious diseases. J. Infect. 71 (2015), 413–421.
50. 50 Mackintosh, J.A., The antimicrobial properties of melanocytes, melanosomes and melanin and the evolution of black skin. J. Theor. Biol. 211 (2001), 101–113.
51. 51 Kippenberger, S., et al. Candida albicans suppresses transcription of melanogenesis enzymes in cultured melanocytes. Mycoses 40 (1997), 373–375.
52. 52 Tapia, C.V., et al. Melanocytes and melanin represent a first line of innate immunity against Candida albicans. Med. Mycol. 52 (2014), 445–454.
53. 53 Ordovas-Montanes, J., et al. The regulation of immunological processes by peripheral neurons in homeostasis and disease. Trends Immunol. 36 (2015), 578–604.
54. 54 Hosoi, J., et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363 (1993), 159–163.
55. 55 Riol-Blanco, L., et al. Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation. Nature 510 (2014), 157–161.
56. 56 Farmer, M.A., et al. Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia. Sci. Transl. Med., 3, 2011, 101ra91.
57. 57 Ren, K., Dubner, R., Inflammatory models of pain and hyperalgesia. ILAR J. 40 (1999), 111–118.
58. 58 Chiu, I.M., et al. Bacteria activate sensory neurons that modulate pain and inflammation. Nature 501 (2013), 52–57.
59. 59 De Petrocellis, L., et al. Chemical synthesis, pharmacological characterization, and possible formation in unicellular fungi of 3-hydroxy-anandamide. J. Lipid Res. 50 (2009), 658–666.
60. 60 Karim, El, I.A., et al. Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. J. Neuroimmunol. 200 (2008), 11–16.
61. 61 Roggenkamp, D., et al. Epidermal nerve fibers modulate keratinocyte growth via neuropeptide signaling in an innervated skin model. J. Invest. Dermatol. 133 (2013), 1620–1628.
62. 62 Ding, W., et al. Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity. J. Immunol. 181 (2008), 6020–6026.
63. 63 Parham, C., et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168 (2002), 5699–5708.
64. 64 Gaffen, S.L., et al. The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14 (2014), 585–600.
65. 65 de Beaucoudrey, L., et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205 (2008), 1543–1550.
66. 66 Ouederni, M., et al. Clinical features of candidiasis in patients with inherited interleukin 12 receptor β1 deficiency. Clin. Infect. Dis. 58 (2014), 204–213.
67. 67 Whitney, P.G., et al. Syk signaling in dendritic cells orchestrates innate resistance to systemic fungal infection. PLoS Pathog., 10, 2014, e1004276.
68. 68 Conti, H.R., et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206 (2009), 299–311.
69. 69 Maher, C.O., et al. Candida albicans stimulates IL-23 release by human dendritic cells and downstream IL-17 secretion by Vδ1 T cells. J. Immunol. 194 (2015), 5953–5960.
70. 70 Kaplan, D.H., In vivo function of Langerhans cells and dermal dendritic cells. Trends Immunol. 31 (2010), 446–451.
71. 71 Yoshiki, R., et al. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells. J. Invest. Dermatol. 134 (2014), 1912–1921.
72. 72 Wohn, C., et al. Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 10723–10728.
73. + NK cell-mediated skin inflammation. J. Immunol. 195 (2015), 2335–2342.
74. 74 Kaplan, D.H., et al. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23 (2005), 611–620.
75. 75 Bobr, A., et al. Acute ablation of Langerhans cells enhances skin immune responses. J. Immunol. 185 (2010), 4724–4728.
76. 76 Igyártó, B.Z., et al. Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and Langerhans cell-derived IL-10. J. Immunol. 183 (2009), 5085–5093.
77. 77 Huppler, A.R., et al. Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. J. Immunol. 192 (2014), 1745–1752.
78. 78 Trautwein-Weidner, K., et al. IL-17-mediated antifungal defense in the oral mucosa is independent of neutrophils. Mucosal Immunol. 8 (2015), 221–231.
79. 79 Johnston, A., et al. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation. J. Immunol. 190 (2013), 2252–2262.
80. 80 Conti, H.R., et al. Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis. PLoS ONE, 10, 2015, e0122807.
81. 81 Gladiator, A., et al. Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J. Immunol. 190 (2013), 521–525.
82. 82 Conti, H.R., et al. Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections. J. Exp. Med. 211 (2014), 2075–2084.
83. 83 Wilson, R.P., et al. STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function. J. Exp. Med. 212 (2015), 855–864.
84. 84 Cua, D.J., Tato, C.M., Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10 (2010), 479–489.
85. + congenic mouse substrain provides protection from dermatitis. Nat. Immunol. 14 (2013), 584–592.
86. 86 Taylor, P.R., et al. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2. Nat. Immunol. 15 (2014), 143–151.
87. 87 Branzk, N., et al. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat. Immunol. 15 (2014), 1017–1025.
88. 88 Rieber, N., et al. Pathogenic fungi regulate immunity by inducing neutrophilic myeloid-derived suppressor cells. Cell Host Microbe 17 (2015), 507–514.
89. 89 Netea, M.G., et al. Immune defence against Candida fungal infections. Nat. Rev. Immunol. 15 (2015), 630–642.
90. 90 Zielinski, C.E., et al. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 484 (2012), 514–518.
91. 91 Becattini, S., et al. Functional heterogeneity of human memory CD4ζ T cell clones primed by pathogens or vaccines. Science 347 (2015), 400–406.
92. 92 Randall, K.L., et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J. Exp. Med. 208 (2011), 2305–2320.
93. + dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 12782–12787.
94. 94 Naik, S., et al. Commensal–dendritic-cell interaction specifies a unique protective skin immune signature. Nature 520 (2015), 104–108.
95. 95 Trautwein-Weidner, K., et al. Antigen-specific Th17 cells are primed by distinct and complementary dendritic cell subsets in oropharyngeal candidiasis. PLoS Pathog., 11, 2015, e1005164.
96. 96 Hambleton, S., et al. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365 (2011), 127–138.
97. 97 Hernández-Santos, N., et al. Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol. 6 (2013), 900–910.
98. 98 Pepper, M., et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat. Immunol. 11 (2010), 83–89.
99. 99 Ahmad, D.S., et al. Idiopathic CD4 lymphocytopenia: spectrum of opportunistic infections, malignancies, and autoimmune diseases. Avicenna J. Med. 3 (2013), 37–47.
100. + T lymphocytopenia. Int. J. Dermatol. 38 (1999), 119–121.
101. 101 Holland, S.M., et al. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357 (2007), 1608–1619.
102. 102 Milner, J.D., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452 (2008), 773–776.
103. 103 Zhang, Q., et al. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 361 (2009), 2046–2055.
104. 104 Puel, A., et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332 (2011), 65–68.
105. 105 Ling, Y., et al. Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis. J. Exp. Med. 212 (2015), 619–631.
106. 106 Boisson, B., et al. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity 39 (2013), 676–686.
107. 107 Okada, S., et al. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science 349 (2015), 606–613.
108. 108 Kisand, K., et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J. Exp. Med. 207 (2010), 299–308.
109. 109 Liu, L., et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208 (2011), 1635–1648.